3. Results
Fasting blood glucose levels were examined at week 2 and week 16
post-injection. Elevated fasting blood glucose levels (8.6 ± 4.3 mM)
were observed at the third day post-injection. At two weeks both
untreated and treated diabetic mice showed a significant increase in
fasting glucose levels (9.7 ± 1.7 mM, 9.6 ± 1.5 mM,P < 0.05, respectively) compared with that of normal
mice. At 16 weeks both untreated and treated diabetic mice still showed
a significant increase in their fasting glucose levels (9.7 mM ± 1.7,
8.6± 1.3 mM, P < 0.05, respectively) compared with
that of normal mice (Figure 1).